Literature DB >> 25148837

The continuum of personalized cardiovascular medicine: a position paper of the European Society of Cardiology.

Paulus Kirchhof, Karin R Sipido, Martin R Cowie, Thomas Eschenhagen, Keith A A Fox, Hugo Katus, Stefan Schroeder, Heribert Schunkert, Silvia Priori.   

Abstract

There is strong need to develop the current stratified practice of CVD management into a better personalized cardiovascular medicine, within a broad framework of global patient care. Clinical information obtained from history and physical examination, functional and imaging studies, biochemical biomarkers, genetic/epigenetic data, and pathophysiological insights into disease-driving processes need to be integrated into a new taxonomy of CVDs to allow personalized disease management. This has the potential for major health benefits for the population suffering from cardiovascular diseases.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25148837      PMCID： PMC4258224          DOI： 10.1093/eurheartj/ehu312

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


  61 in total

1.  A large candidate gene survey identifies the KCNE1 D85N polymorphism as a possible modulator of drug-induced torsades de pointes.

Authors:  Stefan Kääb; Dana C Crawford; Moritz F Sinner; Elijah R Behr; Prince J Kannankeril; Arthur A M Wilde; Connie R Bezzina; Eric Schulze-Bahr; Pascale Guicheney; Nanette H Bishopric; Robert J Myerburg; Jean-Jacques Schott; Arne Pfeufer; Britt-Maria Beckmann; Eimo Martens; Taifang Zhang; Birgit Stallmeyer; Sven Zumhagen; Isabelle Denjoy; Abdennasser Bardai; Isabelle C Van Gelder; Yalda Jamshidi; Chrysoula Dalageorgou; Vanessa Marshall; Steve Jeffery; Saad Shakir; A John Camm; Gerhard Steinbeck; Siegfried Perz; Peter Lichtner; Thomas Meitinger; Annette Peters; H-Erich Wichmann; Christiana Ingram; Yuki Bradford; Shannon Carter; Kris Norris; Marylyn D Ritchie; Alfred L George; Dan M Roden
Journal:  Circ Cardiovasc Genet       Date:  2011-11-18

Review 2.  A systematic review on pharmacogenetics in cardiovascular disease: is it ready for clinical application?

Authors:  Jeffrey J W Verschuren; Stella Trompet; Judith A M Wessels; Henk-Jan Guchelaar; Moniek P M de Maat; Maarten L Simoons; J Wouter Jukema
Journal:  Eur Heart J       Date:  2011-07-30       Impact factor: 29.983

3.  Prospects of personalized medicine in cardiovascular diseases.

Authors:  Claude Lenfant
Journal:  Metabolism       Date:  2012-09-21       Impact factor: 8.694

4.  Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET/EHRA consensus conference.

Authors:  Paulus Kirchhof; Gregory Y H Lip; Isabelle C Van Gelder; Jeroen Bax; Elaine Hylek; Stefan Kääb; Ulrich Schotten; Karl Wegscheider; Giuseppe Boriani; Michael Ezekowitz; Hans Diener; Hein Heidbuchel; Deirdre Lane; Luis Mont; Stephan Willems; Paul Dorian; Panos Vardas; Günter Breithardt; A John Camm
Journal:  Thromb Haemost       Date:  2011-11-02       Impact factor: 5.249

Review 5.  European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).

Authors: 
Journal:  Eur J Prev Cardiol       Date:  2012-07-04       Impact factor: 7.804

6.  Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006.

Authors:  Keith A A Fox; Philippe Gabriel Steg; Kim A Eagle; Shaun G Goodman; Frederick A Anderson; Christopher B Granger; Marcus D Flather; Andrzej Budaj; Ann Quill; Joel M Gore
Journal:  JAMA       Date:  2007-05-02       Impact factor: 56.272

7.  Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.

Authors:  Gregory Y H Lip; Robby Nieuwlaat; Ron Pisters; Deirdre A Lane; Harry J G M Crijns
Journal:  Chest       Date:  2009-09-17       Impact factor: 9.410

8.  Giant T-U waves precede torsades de pointes in long QT syndrome: a systematic electrocardiographic analysis in patients with acquired and congenital QT prolongation.

Authors:  Paulus Kirchhof; Michael R Franz; Abdennasser Bardai; Arthur M Wilde
Journal:  J Am Coll Cardiol       Date:  2009-07-07       Impact factor: 24.094

9.  Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care.

Authors:  M R Cowie; A D Struthers; D A Wood; A J Coats; S G Thompson; P A Poole-Wilson; G C Sutton
Journal:  Lancet       Date:  1997-11-08       Impact factor: 79.321

10.  SLCO1B1 variants and statin-induced myopathy--a genomewide study.

Authors:  E Link; S Parish; J Armitage; L Bowman; S Heath; F Matsuda; I Gut; M Lathrop; R Collins
Journal:  N Engl J Med       Date:  2008-07-23       Impact factor: 91.245
View more
  24 in total

1.  Debate: Molecular cardiac imaging is ready for the prime time con between wishful thinking and reality.

Authors:  Ignasi Carrió
Journal:  J Nucl Cardiol       Date:  2015-11-05       Impact factor: 5.952

Review 2.  Medical care and drug-related problems: Do doctors and pharmacists speak the same language?

Authors:  J W Foppe van Mil; Tommy Westerlund; Lawrence Brown; Timothy F Chen; Martin Henman; Kurt Hersberger; James McElnay; Martin Schulz
Journal:  Int J Clin Pharm       Date:  2016-01-21

Review 3.  Long noncoding RNAs in cardiac development and ageing.

Authors:  Yvan Devaux; Jennifer Zangrando; Blanche Schroen; Esther E Creemers; Thierry Pedrazzini; Ching-Pin Chang; Gerald W Dorn; Thomas Thum; Stephane Heymans
Journal:  Nat Rev Cardiol       Date:  2015-04-07       Impact factor: 32.419

4.  Dual-energy CT: a phantom comparison of different platforms for abdominal imaging.

Authors:  Thorsten Sellerer; Peter B Noël; Manuel Patino; Anushri Parakh; Sebastian Ehn; Sascha Zeiter; Jasmin A Holz; Johannes Hammel; Alexander A Fingerle; Franz Pfeiffer; David Maintz; Ernst J Rummeny; Daniela Muenzel; Dushyant V Sahani
Journal:  Eur Radiol       Date:  2018-02-05       Impact factor: 5.315

5.  Personalized treatment of heart failure with biomarker guidance using a novel disease severity score.

Authors:  Anupama Vasudevan; Hourossadat Hashemi Jazi; Jane I Won; Timothy Ball; Gautam R Patankar; Syed A Sarmast; Hyun Joon Shin; Peter A McCullough
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-04

6.  Health Services Research: Cardiology in the Changing Health Care Landscape.

Authors:  Joseph Ebinger
Journal:  J Am Coll Cardiol       Date:  2017-05-02       Impact factor: 24.094

Review 7.  Advances in Genomic Discovery and Implications for Personalized Prevention and Medicine: Estonia as Example.

Authors:  Bram Peter Prins; Liis Leitsalu; Katri Pärna; Krista Fischer; Andres Metspalu; Toomas Haller; Harold Snieder
Journal:  J Pers Med       Date:  2021-04-29

Review 8.  The prognostic role of speckle tracking echocardiography in clinical practice: evidence and reference values from the literature.

Authors:  Maria Concetta Pastore; Giuseppe De Carli; Giulia Elena Mandoli; Flavio D'Ascenzi; Marta Focardi; Francesco Contorni; Sergio Mondillo; Matteo Cameli
Journal:  Heart Fail Rev       Date:  2021-11       Impact factor: 4.214

Review 9.  Expert consensus document: Defining the major health modifiers causing atrial fibrillation: a roadmap to underpin personalized prevention and treatment.

Authors:  Larissa Fabritz; Eduard Guasch; Charalambos Antoniades; Isabel Bardinet; Gerlinde Benninger; Tim R Betts; Eva Brand; Günter Breithardt; Gabriela Bucklar-Suchankova; A John Camm; David Cartlidge; Barbara Casadei; Winnie W L Chua; Harry J G M Crijns; Jon Deeks; Stéphane Hatem; Françoise Hidden-Lucet; Stefan Kääb; Nikos Maniadakis; Stephan Martin; Lluis Mont; Holger Reinecke; Moritz F Sinner; Ulrich Schotten; Taunton Southwood; Monika Stoll; Panos Vardas; Reza Wakili; Andy West; André Ziegler; Paulus Kirchhof
Journal:  Nat Rev Cardiol       Date:  2015-12-24       Impact factor: 32.419

Review 10.  Atrial fibrillation in heart failure: what should we do?

Authors:  Dipak Kotecha; Jonathan P Piccini
Journal:  Eur Heart J       Date:  2015-09-28       Impact factor: 29.983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.